Literature DB >> 22416203

The serum vancomycin assay: A test of historic interest.

S Shafran1, J Conly.   

Abstract

Entities:  

Year:  1995        PMID: 22416203      PMCID: PMC3298056          DOI: 10.1155/1995/154760

Source DB:  PubMed          Journal:  Can J Infect Dis        ISSN: 1180-2332


× No keyword cloud information.
  10 in total

1.  Once-daily aminoglycoside dosing: A new look at an old drug.

Authors:  J Conly; W Gold; S Shafran
Journal:  Can J Infect Dis       Date:  1994-09

2.  Routine monitoring of serum vancomycin concentrations: waiting for proof of its value.

Authors:  D J Edwards; S Pancorbo
Journal:  Clin Pharm       Date:  1987-08

3.  Routine monitoring of serum vancomycin concentrations: can waiting be justified?

Authors:  K A Rodvold; H Zokufa; J C Rotschafer
Journal:  Clin Pharm       Date:  1987-08

Review 4.  Monitoring serum vancomycin levels: climbing the mountain because it is there?

Authors:  R C Moellering
Journal:  Clin Infect Dis       Date:  1994-04       Impact factor: 9.079

Review 5.  Serum vancomycin concentrations: reappraisal of their clinical value.

Authors:  T G Cantú; N A Yamanaka-Yuen; P S Lietman
Journal:  Clin Infect Dis       Date:  1994-04       Impact factor: 9.079

6.  Monitoring vancomycin therapy.

Authors:  M J Rybak; S C Boike
Journal:  Drug Intell Clin Pharm       Date:  1986-10

Review 7.  Vancomycin therapeutic drug monitoring: is it necessary?

Authors:  C D Freeman; R Quintiliani; C H Nightingale
Journal:  Ann Pharmacother       Date:  1993-05       Impact factor: 3.154

8.  Removal of vancomycin by high-flux hemodialysis membranes.

Authors:  J M Quale; J J O'Halloran; N DeVincenzo; R H Barth
Journal:  Antimicrob Agents Chemother       Date:  1992-07       Impact factor: 5.191

9.  Vancomycin therapy in patients with impaired renal function: a nomogram for dosage.

Authors:  R C Moellering; D J Krogstad; D J Greenblatt
Journal:  Ann Intern Med       Date:  1981-03       Impact factor: 25.391

10.  The epidemiology of intravenous vancomycin usage in a university hospital. A 10-year study.

Authors:  J Ena; R W Dick; R N Jones; R P Wenzel
Journal:  JAMA       Date:  1993-02-03       Impact factor: 56.272

  10 in total
  2 in total

1.  Strategies for controlling antibiotic use in a tertiary-care paediatric hospital.

Authors:  S A Diamond; B J Hales
Journal:  Paediatr Child Health       Date:  1997-05       Impact factor: 2.253

2.  Vancomycin Serum Concentration Monitoring : The Middle Ground is Best.

Authors:  F Marra; B Cairns; P Jewesson
Journal:  Clin Drug Investig       Date:  1996-08       Impact factor: 2.859

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.